Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 7:14 PM
Ignite Modification Date:
2025-12-25 @ 4:50 PM
NCT ID:
NCT03896503
Group ID:
EG002
Title:
Platinum Response - Resistant: Topotecan Monotherapy
Description:
Arm I (topotecan hydrochloride) Participants with pulmonary disease receive topotecan hydrochloride intravenously (IV) over 30 minutes on days 1-5. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity. Participants may crossover to Arm II at disease progression. Participants undergo a computed tomography (CT) scan during screening and on study as well as a tumor biopsy during screening. Participants may also undergo blood sample collection during screening and on study.
Deaths Number Affected:
11
Deaths Number At Risk:
None
Serious Number Affected:
9
Serious Number At Risk:
11
Other Number Affected:
11
Other Number At Risk:
11
Study:
NCT03896503
Results Section:
NCT03896503
Adverse Events Module:
NCT03896503